Wells Fargo & Company Issues Positive Forecast for Septerna (NASDAQ:SEPN) Stock Price

Septerna (NASDAQ:SEPN) had its price target hoisted by equities research analysts at Wells Fargo & Company from $50.00 to $61.00 in a report released on Wednesday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target would indicate a potential upside of 30.69% from the company’s current price.

Several other research analysts have also weighed in on SEPN. HC Wainwright increased their target price on shares of Septerna from $40.00 to $60.00 and gave the stock a “buy” rating in a research note on Wednesday, August 12th. Raymond James Financial reissued a “strong-buy” rating and issued a $49.00 price target on shares of Septerna in a research note on Tuesday, August 11th. JPMorgan Chase & Co. upped their price objective on shares of Septerna from $38.00 to $48.00 and gave the stock an “overweight” rating in a report on Wednesday, August 19th. JonesTrading increased their price objective on shares of Septerna from $43.00 to $62.00 and gave the stock a “buy” rating in a research report on Thursday, August 13th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Septerna in a report on Thursday, October 15th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Septerna has a consensus rating of “Moderate Buy” and an average price target of $53.67.

Septerna Stock Performance

Shares of Septerna stock traded up $2.97 during trading hours on Wednesday, hitting $46.67. The company’s stock had a trading volume of 75,924 shares, compared to its average volume of 360,455. The stock has a market cap of $2.18 billion, a price-to-earnings ratio of -86.42 and a beta of 2.20. Septerna has a twelve month low of $17.55 and a twelve month high of $51.10. The firm has a fifty day moving average of $39.08 and a 200-day moving average of $32.27.

Septerna (NASDAQ:SEPN) last issued its quarterly earnings data on Monday, August 10th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.43) by $0.14. The firm had revenue of $26.75 million during the quarter, compared to the consensus estimate of $19.22 million. Septerna had a negative return on equity of 9.57% and a negative net margin of 24.51%. On average, sell-side analysts expect that Septerna will post -1.41 earnings per share for the current fiscal year.

Insider Buying and Selling at Septerna

In related news, COO Elizabeth Bhatt sold 4,000 shares of the business’s stock in a transaction on Thursday, October 15th. The stock was sold at an average price of $37.41, for a total transaction of $149,640.00. Following the completion of the transaction, the chief operating officer directly owned 174,209 shares of the company’s stock, valued at $6,517,158.69. The trade was a 2.24% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Daniel D. Long sold 3,333 shares of the company’s stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $37.83, for a total value of $126,087.39. Following the sale, the senior vice president owned 96,412 shares in the company, valued at approximately $3,647,265.96. This trade represents a 3.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 32,333 shares of company stock worth $1,375,727. Insiders own 5.80% of the company’s stock.

Hedge Funds Weigh In On Septerna

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Covestor Ltd increased its stake in shares of Septerna by 19.0% during the third quarter. Covestor Ltd now owns 2,526 shares of the company’s stock worth $98,000 after buying an additional 403 shares during the period. Sterling Capital Management LLC raised its holdings in Septerna by 215.0% in the third quarter. Sterling Capital Management LLC now owns 630 shares of the company’s stock valued at $25,000 after acquiring an additional 430 shares in the last quarter. Engineers Gate Manager LP lifted its stake in Septerna by 5.0% in the second quarter. Engineers Gate Manager LP now owns 17,350 shares of the company’s stock worth $581,000 after acquiring an additional 822 shares during the last quarter. China Universal Asset Management Co. Ltd. lifted its stake in Septerna by 12.5% in the third quarter. China Universal Asset Management Co. Ltd. now owns 12,117 shares of the company’s stock worth $474,000 after acquiring an additional 1,343 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. purchased a new position in Septerna in the third quarter worth approximately $93,000.

About Septerna

Septerna, Inc is a clinical-stage biotechnology company focused on discovering and developing oral small-molecule medicines that target G protein-coupled receptors (GPCRs). GPCRs are a large class of cell-surface proteins involved in a wide range of biological processes and represent an important source of potential drug targets.

The company’s research is powered by its Native State platform, which is designed to study GPCRs in their natural biological configuration and support the discovery of selective small-molecule compounds.